For example, small molecules targeting key components of SEs, such as BRD4 (101), p300 (102) and CDK7 (103), have been studied in multiple myeloma, autoimmune diseases and cancer drugs, respectively. The gene discussed is CDK7; the disease is plasma cell myeloma.